Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · RAAJ MEDISAFE INDIA LTD. · 28 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
RAAJ MEDISAFE INDIA LTD. BSE: 524502
Industrials › Capital Goods › Industrial Products › Packaging
RAAJ MEDISAFE INDIA LTD.
StateQ4 FY26 filed
Last close · 27 Oct 2026₹102.11
Market cap₹0.1k cr
TTM P/E · P/B · EV/EBITDA17.5 · 2.87 · 15.1
RAAJ MEDISAFE INDIA LTD. is a Industrial Products company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
₹ crore · standalone
FY22
FY23
FY24
FY25
FY26
Revenue
35
39
43
62
80
EBITDA (ex other income)
5
6
7
9
12
margin %
14.8
14.5
15.3
13.8
14.7
Owners' profit
3
3
3
6
2
EPS, as reported (₹)
2.82
3.06
3.07
4.60
1.10
ROE % · ROCE %
72.6 · 43.9
44.5 · 33.8
30.7 · 23.0
22.8 · 17.9
3.9 · 12.0
Debt / equity (x)
3.14
2.08
2.39
1.28
1.37
Cash from operations
2
0
4
(0)
4
Capex
(1)
(2)
(12)
(15)
(33)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · RAAJ MEDISAFE INDIA LTD. · 28 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
₹ crore
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Q2 FY26
Q3 FY26
Q4 FY26
Revenue
11
13
15
24
16
18
21
25
Profit before tax
1
1
1
2
1
2
2
1
Net profit
1
1
1
3
1
2
2
(3)
EPS (₹)
0.74
0.49
0.76
2.61
1.11
1.32
1.44
1.96
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Segment revenue, FY26
Segment
Revenue, ₹ crore
Share %
PLASTIC
40
49.4
HYGIENE
10
12.4
Plastic
14
17.7
Hygiene
7
8.1
HYIGENE
10
12.4
Total, before eliminations
81
100.0
Source: the filed segment block, four quarters summed.
Exhibit 4: Peers — basic industry group, by market cap
Company
M.cap ₹ cr
P/E
P/B
EV/EBITDA
ROE %
ROCE %
Rev CAGR 5y %
EBITDA m. %
EPL LIMITED
7,122
14.6
2.48
7.8
13.7
13.6
9.0
19.1
AGI GREENPAC LIMITED
4,672
12.9
1.94
7.1
14.6
16.5
—
23.4
UFLEX LIMITED
4,177
6.1
0.51
6.6
3.9
2.7
11.6
17.1
TCPL PACKAGING LIMITED
3,700
32.0
5.15
14.0
13.6
13.0
15.4
17.8
JINDAL POLY FILMS LIMITED
2,999
146.7
0.74
10.1
0.6
0.8
8.5
23.0
POLYPLEX CORPORATION LTD
2,900
18.7
0.41
8.0
0.6
0.3
7.6
14.3
XPRO INDIA LIMITED
2,359
71.4
2.95
51.2
2.4
2.8
6.2
11.4
COSMO FIRST LIMITED
1,940
11.5
1.20
7.3
9.6
6.4
9.8
12.6
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 5: Where the company sits in its group
Metric
Company
Group median
Rank
Better than
P/E (TTM)
17.5
16.6
36 of 64
41%
P/B
2.9
1.3
48 of 61
22%
ROCE
7.3
6.9
34 of 68
51%
ROE
3.9
6.8
37 of 61
40%
Debt / Equity
1.4
0.4
55 of 61
10%
EBITDA margin
11.9
12.1
32 of 62
49%
Revenue growth
2.8
14.0
43 of 61
30%
Profit growth
(192.7)
23.4
57 of 60
5%
Market cap
134
113
35 of 73
53%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · RAAJ MEDISAFE INDIA LTD. · 28 October 2026Page 3 of 3
Exhibit 6: Filings of the last 90 days, with the measured price reaction
Date · filing
Category
Importance
Next day %
5-day %
12 Oct 2026 · RTA files quarterly demat confirmation certificate for quarter ended September 2026
compliance
minimal
—
—
22 Sept 2026 · 41st AGM results: All resolutions passed including related party transactions
compliance
minimal
—
—
22 Sept 2026 · 41st AGM proceedings held via video conferencing on Sept 21, 2026
board shareholder meetings
low
—
—
21 Sept 2026 · 41st AGM held; FY26 accounts adopted, director and related party deals approved
board shareholder meetings
low
—
—
19 Sept 2026 · Trading Window Closed from Oct 1, 2026 Pending Q2 Results
compliance
minimal
—
—
16 Sept 2026 · Promoter Krishna Jajoo gifts 26,993 shares to Vishnu Jajoo HUF via inter-se transfer
16 Sept 2026 · Inter-se gift transfer to Vishnu Jajoo HUF of 1.35% promoter shares
ownership changes
low
—
—
31 Aug 2026 · Raaj Medisafe wins Rs 17.02 Cr diaper supply order from MP Govt
business updates
high
—
—
29 Aug 2026 · AGM on Sep 21, 2026; book closure Sep 15 to Sep 21
board shareholder meetings
low
—
—
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
Where a broker report shows
This document shows
Why
A rating (BUY / ADD / REDUCE / SELL)
A state: the latest filed quarter and the measured reactions
an event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upside
The current price and the multiples against the group
a target is a forecast; a multiple is a measurement
Estimate years marked E
More audited years; no estimates
MarketPing publishes no forecasts — your own model lives on the Models page
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in